mondo_id	property	value_old	value_new
MONDO:0700066	label	myopathy caused by varation in FKRP	myopathy caused by variation in FKRP
MONDO:0700068	label	myopathy caused by varation in POMGNT1	myopathy caused by variation in POMGNT1
MONDO:0000881	label	myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1	obsolete myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
MONDO:0000882	label	myeloid and lymphoid neoplasms associated with PDGFRA rearrangement	obsolete myeloid and lymphoid neoplasms associated with PDGFRA rearrangement
MONDO:0000883	label	myeloid neoplasms associated with PDGFRB rearrangement	obsolete myeloid neoplasms associated with PDGFRB rearrangement
MONDO:0000912	label	autosomal recessive nonsyndromic deafness 5	autosomal recessive nonsyndromic hearing loss 5
MONDO:0019588	label	deafness, autosomal recessive	hearing loss, autosomal recessive
MONDO:0002145	label	sex differentiation disease	difference of sexual differentiation
MONDO:0019589	label	syndromic genetic deafness	syndromic genetic hearing loss
MONDO:0006475	label	unclassified renal cell carcinoma	obsolete unclassified renal cell carcinoma
MONDO:0006728	label	discitis	obsolete discitis
MONDO:0017957	label	unclassified autoinflammatory syndrome	obsolete unclassified autoinflammatory syndrome
MONDO:0007424	label	autosomal dominant nonsyndromic deafness 1	autosomal dominant nonsyndromic hearing loss 1
MONDO:0019587	label	autosomal dominant nonsyndromic deafness	autosomal dominant nonsyndromic hearing loss
MONDO:0007684	label	granulomatous disease, chronic, autosomal dominant type	obsolete granulomatous disease, chronic, autosomal dominant type
MONDO:0007815	label	immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist	obsolete immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
MONDO:0007850	label	autosomal dominant keratitis-ichthyosis-deafness syndrome	autosomal dominant keratitis-ichthyosis-hearing loss syndrome
MONDO:0008083	label	neuronal ceroid lipofuscinosis 4B	ceroid lipofuscinosis, neuronal, 4 (Kufs type)
MONDO:0008091	label	abnormal neutrophil chemotactic response	obsolete abnormal neutrophil chemotactic response
MONDO:0008122	label	olivopontocerebellar atrophy 5	obsolete olivopontocerebellar atrophy 5
MONDO:0020244	label	unclassified primitive or secondary maculopathy	obsolete unclassified primitive or secondary maculopathy
MONDO:0008768	label	neuronal ceroid lipofuscinosis 4A	ceroid lipofuscinosis, neuronal, 6B (Kufs type)
MONDO:0008956	label	congenital neuronal ceroid lipofuscinosis	obsolete congenital neuronal ceroid lipofuscinosis
MONDO:0008960	label	Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome	Charcot-Marie-Tooth disease-hearing loss-intellectual disability syndrome
MONDO:0009004	label	combined inflammatory and immunologic defect	obsolete combined inflammatory and immunologic defect
MONDO:0009076	label	autosomal recessive nonsyndromic deafness 1A	autosomal recessive nonsyndromic hearing loss 1A
MONDO:0009090	label	deafness, sensorineural, autosomal-mitochondrial type	hearing loss, sensorineural, autosomal-mitochondrial type
MONDO:0010779	label	mitochondrial non-syndromic sensorineural deafness	mitochondrial non-syndromic sensorineural hearing loss
MONDO:0009342	label	Hirschsprung disease-deafness-polydactyly syndrome	Hirschsprung disease-hearing loss-polydactyly syndrome
MONDO:0700070	label	myopathy caused by varation in POMT1	myopathy caused by variation in POMT1
MONDO:0009440	label	ichthyosiform erythroderma, corneal involvement, and deafness	ichthyosiform erythroderma, corneal involvement, and hearing loss
MONDO:0009494	label	Ketoadipicaciduria	obsolete Ketoadipicaciduria
MONDO:0009535	label	lymphedema, congenital recessive	obsolete lymphedema, congenital recessive
MONDO:0009654	label	mucopolysaccharidoses, unclassified types	obsolete mucopolysaccharidoses, unclassified types
MONDO:0700067	label	myopathy caused by varation in FKTN	myopathy caused by variation in FKTN
MONDO:0009799	label	pachydermoperiostosis	obsolete pachydermoperiostosis
MONDO:0010228	label	deafness, X-linked 3	hearing loss, X-linked 3
MONDO:0019586	label	X-linked nonsyndromic deafness	X-linked nonsyndromic hearing loss
MONDO:0010238	label	deafness, X-linked 4	hearing loss, X-linked 4
MONDO:0010378	label	X-linked hereditary sensory and autonomic neuropathy with deafness	X-linked hereditary sensory and autonomic neuropathy with hearing loss
MONDO:0010403	label	albinism-deafness syndrome	albinism-hearing loss syndrome
MONDO:0010484	label	deafness, X-linked 6	hearing loss, X-linked 6
MONDO:0010527	label	microphthalmia-ankyloblepharon-intellectual disability syndrome	obsolete microphthalmia-ankyloblepharon-intellectual disability syndrome
MONDO:0010576	label	X-linked mixed deafness with perilymphatic gusher	X-linked mixed hearing loss with perilymphatic gusher
MONDO:0010577	label	deafness, X-linked 1	hearing loss, X-linked 1
MONDO:0010764	label	deafness, Y-linked 1	hearing loss, Y-linked 1
MONDO:0016297	label	prelingual non-syndromic genetic deafness	prelingual non-syndromic genetic hearing loss
MONDO:0016298	label	postlingual non-syndromic genetic deafness	postlingual non-syndromic genetic hearing loss
MONDO:0010799	label	aminoglycoside-induced deafness	aminoglycoside-induced hearing loss
MONDO:0010807	label	autosomal recessive nonsyndromic deafness 2	autosomal recessive nonsyndromic hearing loss 2
MONDO:0010817	label	autosomal dominant nonsyndromic deafness 2A	autosomal dominant nonsyndromic hearing loss 2A
MONDO:0010860	label	autosomal recessive nonsyndromic deafness 3	autosomal recessive nonsyndromic hearing loss 3
MONDO:0010915	label	autosomal dominant nonsyndromic deafness 4A	autosomal dominant nonsyndromic hearing loss 4A
MONDO:0010918	label	EIG1	epilepsy, idiopathic generalized, susceptibility to, 1
MONDO:0010933	label	autosomal recessive nonsyndromic deafness 4	autosomal recessive nonsyndromic hearing loss 4
MONDO:0010963	label	autosomal dominant nonsyndromic deafness 6	autosomal dominant nonsyndromic hearing loss 6
MONDO:0010965	label	autosomal recessive nonsyndromic deafness 6	autosomal recessive nonsyndromic hearing loss 6
MONDO:0010967	label	autosomal recessive nonsyndromic deafness 7	autosomal recessive nonsyndromic hearing loss 7
MONDO:0010973	label	autosomal dominant nonsyndromic deafness 5	autosomal dominant nonsyndromic hearing loss 5
MONDO:0010986	label	autosomal recessive nonsyndromic deafness 9	autosomal recessive nonsyndromic hearing loss 9
MONDO:0010987	label	autosomal recessive nonsyndromic deafness 8	autosomal recessive nonsyndromic hearing loss 8
MONDO:0011031	label	autosomal dominant nonsyndromic deafness 10	autosomal dominant nonsyndromic hearing loss 10
MONDO:0011032	label	autosomal dominant nonsyndromic deafness 11	autosomal dominant nonsyndromic hearing loss 11
MONDO:0011058	label	autosomal dominant nonsyndromic deafness 9	autosomal dominant nonsyndromic hearing loss 9
MONDO:0011067	label	autosomal recessive nonsyndromic deafness 12	autosomal recessive nonsyndromic hearing loss 12
MONDO:0011074	label	autosomal dominant nonsyndromic deafness 7	autosomal dominant nonsyndromic hearing loss 7
MONDO:0011102	label	autosomal dominant nonsyndromic deafness 12	autosomal dominant nonsyndromic hearing loss 12
MONDO:0011103	label	autosomal dominant nonsyndromic deafness 3A	autosomal dominant nonsyndromic hearing loss 3A
MONDO:0011144	label	neuronal ceroid lipofuscinosis 6	ceroid lipofuscinosis, neuronal, 6A
MONDO:0011159	label	autosomal dominant nonsyndromic deafness 13	autosomal dominant nonsyndromic hearing loss 13
MONDO:0011160	label	autosomal recessive nonsyndromic deafness 15	autosomal recessive nonsyndromic hearing loss 15
MONDO:0011192	label	autosomal recessive nonsyndromic deafness 18A	autosomal recessive nonsyndromic hearing loss 18A
MONDO:0011226	label	autosomal dominant nonsyndromic deafness 15	autosomal dominant nonsyndromic hearing loss 15
MONDO:0011245	label	ichthyosis, hystrix-like, with deafness	ichthyosis, hystrix-like, with hearing loss
MONDO:0011279	label	autosomal recessive nonsyndromic deafness 17	autosomal recessive nonsyndromic hearing loss 17
MONDO:0011286	label	autosomal recessive nonsyndromic deafness 13	autosomal recessive nonsyndromic hearing loss 13
MONDO:0011329	label	cerebral palsy, spastic quadriplegic, 1	obsolete cerebral palsy, spastic quadriplegic, 1
MONDO:0011350	label	autosomal dominant nonsyndromic deafness 17	autosomal dominant nonsyndromic hearing loss 17
MONDO:0011351	label	autosomal recessive nonsyndromic deafness 21	autosomal recessive nonsyndromic hearing loss 21
MONDO:0011360	label	autosomal recessive nonsyndromic deafness 14	autosomal recessive nonsyndromic hearing loss 14
MONDO:0011364	label	autosomal recessive nonsyndromic deafness 16	autosomal recessive nonsyndromic hearing loss 16
MONDO:0011389	label	autosomal dominant nonsyndromic deafness 16	autosomal dominant nonsyndromic hearing loss 16
MONDO:0011392	label	autosomal recessive nonsyndromic deafness 20	autosomal recessive nonsyndromic hearing loss 20
MONDO:0011480	label	autosomal dominant nonsyndromic deafness 20	autosomal dominant nonsyndromic hearing loss 20
MONDO:0011519	label	autosomal dominant nonsyndromic deafness 23	autosomal dominant nonsyndromic hearing loss 23
MONDO:0011553	label	autosomal recessive nonsyndromic deafness 26	autosomal recessive nonsyndromic hearing loss 26
MONDO:0011568	label	autosomal dominant nonsyndromic deafness 25	autosomal dominant nonsyndromic hearing loss 25
MONDO:0011602	label	autosomal recessive nonsyndromic deafness 27	autosomal recessive nonsyndromic hearing loss 27
MONDO:0011625	label	autosomal dominant nonsyndromic deafness 18	autosomal dominant nonsyndromic hearing loss 18
MONDO:0011657	label	autosomal dominant nonsyndromic deafness 24	autosomal dominant nonsyndromic hearing loss 24
MONDO:0011660	label	autosomal dominant nonsyndromic deafness 22	autosomal dominant nonsyndromic hearing loss 22
MONDO:0011673	label	autosomal dominant nonsyndromic deafness 30	autosomal dominant nonsyndromic hearing loss 30
MONDO:0011708	label	autosomal dominant nonsyndromic deafness 36	autosomal dominant nonsyndromic hearing loss 36
MONDO:0011761	label	autosomal dominant nonsyndromic deafness 21	autosomal dominant nonsyndromic hearing loss 21
MONDO:0011762	label	autosomal recessive nonsyndromic deafness 22	autosomal recessive nonsyndromic hearing loss 22
MONDO:0011767	label	autosomal recessive nonsyndromic deafness 31	autosomal recessive nonsyndromic hearing loss 31
MONDO:0011774	label	autosomal recessive nonsyndromic deafness 30	autosomal recessive nonsyndromic hearing loss 30
MONDO:0011799	label	autosomal recessive nonsyndromic deafness 33	autosomal recessive nonsyndromic hearing loss 33
MONDO:0011832	label	autosomal dominant nonsyndromic deafness 44	autosomal dominant nonsyndromic hearing loss 44
MONDO:0011893	label	autosomal dominant nonsyndromic deafness 52	autosomal dominant nonsyndromic hearing loss 52
MONDO:0011912	label	autosomal recessive nonsyndromic deafness 37	autosomal recessive nonsyndromic hearing loss 37
MONDO:0011920	label	autosomal dominant nonsyndromic deafness 48	autosomal dominant nonsyndromic hearing loss 48
MONDO:0011991	label	autosomal recessive nonsyndromic deafness 38	autosomal recessive nonsyndromic hearing loss 38
MONDO:0011994	label	autosomal dominant nonsyndromic deafness 41	autosomal dominant nonsyndromic hearing loss 41
MONDO:0012002	label	autosomal recessive nonsyndromic deafness 40	autosomal recessive nonsyndromic hearing loss 40
MONDO:0012003	label	autosomal recessive nonsyndromic deafness 39	autosomal recessive nonsyndromic hearing loss 39
MONDO:0012023	label	autosomal dominant nonsyndromic deafness 49	autosomal dominant nonsyndromic hearing loss 49
MONDO:0012030	label	autosomal dominant nonsyndromic deafness 43	autosomal dominant nonsyndromic hearing loss 43
MONDO:0012060	label	autosomal recessive nonsyndromic deafness 35	autosomal recessive nonsyndromic hearing loss 35
MONDO:0012083	label	autosomal dominant nonsyndromic deafness 28	autosomal dominant nonsyndromic hearing loss 28
MONDO:0012086	label	autosomal dominant nonsyndromic deafness 31	autosomal dominant nonsyndromic hearing loss 31
MONDO:0012090	label	autosomal dominant nonsyndromic deafness 47	autosomal dominant nonsyndromic hearing loss 47
MONDO:0012091	label	autosomal recessive nonsyndromic deafness 32	autosomal recessive nonsyndromic hearing loss 32
MONDO:0012170	label	autosomal recessive nonsyndromic deafness 36	autosomal recessive nonsyndromic hearing loss 36
MONDO:0012273	label	autosomal recessive nonsyndromic deafness 48	autosomal recessive nonsyndromic hearing loss 48
MONDO:0012293	label	autosomal recessive nonsyndromic deafness 23	autosomal recessive nonsyndromic hearing loss 23
MONDO:0012326	label	autosomal recessive nonsyndromic deafness 42	autosomal recessive nonsyndromic hearing loss 42
MONDO:0012327	label	autosomal recessive nonsyndromic deafness 46	autosomal recessive nonsyndromic hearing loss 46
MONDO:0012333	label	autosomal recessive nonsyndromic deafness 53	autosomal recessive nonsyndromic hearing loss 53
MONDO:0012355	label	autosomal recessive nonsyndromic deafness 28	autosomal recessive nonsyndromic hearing loss 28
MONDO:0012370	label	autosomal recessive nonsyndromic deafness 51	autosomal recessive nonsyndromic hearing loss 51
MONDO:0012375	label	autosomal recessive nonsyndromic deafness 47	autosomal recessive nonsyndromic hearing loss 47
MONDO:0012376	label	autosomal recessive nonsyndromic deafness 55	autosomal recessive nonsyndromic hearing loss 55
MONDO:0012380	label	autosomal dominant nonsyndromic deafness 53	autosomal dominant nonsyndromic hearing loss 53
MONDO:0012418	label	autosomal recessive nonsyndromic deafness 62	autosomal recessive nonsyndromic hearing loss 62
MONDO:0012420	label	autosomal recessive nonsyndromic deafness 49	autosomal recessive nonsyndromic hearing loss 49
MONDO:0012421	label	autosomal recessive nonsyndromic deafness 44	autosomal recessive nonsyndromic hearing loss 44
MONDO:0012442	label	autosomal recessive nonsyndromic deafness 66	autosomal recessive nonsyndromic hearing loss 66
MONDO:0012445	label	autosomal recessive nonsyndromic deafness 59	autosomal recessive nonsyndromic hearing loss 59
MONDO:0012452	label	autosomal recessive nonsyndromic deafness 65	autosomal recessive nonsyndromic hearing loss 65
MONDO:0012460	label	autosomal recessive nonsyndromic deafness 67	autosomal recessive nonsyndromic hearing loss 67
MONDO:0012485	label	autosomal recessive nonsyndromic deafness 68	autosomal recessive nonsyndromic hearing loss 68
MONDO:0012602	label	autosomal recessive nonsyndromic deafness 24	autosomal recessive nonsyndromic hearing loss 24
MONDO:0012670	label	autosomal recessive nonsyndromic deafness 63	autosomal recessive nonsyndromic hearing loss 63
MONDO:0012902	label	autosomal dominant nonsyndromic deafness 27	autosomal dominant nonsyndromic hearing loss 27
MONDO:0012903	label	autosomal recessive nonsyndromic deafness 45	autosomal recessive nonsyndromic hearing loss 45
MONDO:0012974	label	autosomal dominant nonsyndromic deafness 59	autosomal dominant nonsyndromic hearing loss 59
MONDO:0012975	label	autosomal dominant nonsyndromic deafness 3B	autosomal dominant nonsyndromic hearing loss 3B
MONDO:0012976	label	autosomal dominant nonsyndromic deafness 2B	autosomal dominant nonsyndromic hearing loss 2B
MONDO:0012977	label	autosomal recessive nonsyndromic deafness 1B	autosomal recessive nonsyndromic hearing loss 1B
MONDO:0013010	label	autosomal recessive nonsyndromic deafness 71	autosomal recessive nonsyndromic hearing loss 71
MONDO:0013114	label	autosomal dominant nonsyndromic deafness 50	autosomal dominant nonsyndromic hearing loss 50
MONDO:0013119	label	autosomal recessive nonsyndromic deafness 77	autosomal recessive nonsyndromic hearing loss 77
MONDO:0700071	label	myopathy caused by varation in POMT2	myopathy caused by variation in POMT2
MONDO:0013210	label	autosomal recessive nonsyndromic deafness 25	autosomal recessive nonsyndromic hearing loss 25
MONDO:0013215	label	autosomal recessive nonsyndromic deafness 79	autosomal recessive nonsyndromic hearing loss 79
MONDO:0013249	label	autosomal recessive nonsyndromic deafness 84A	autosomal recessive nonsyndromic hearing loss 84A
MONDO:0013250	label	autosomal recessive nonsyndromic deafness 85	autosomal recessive nonsyndromic hearing loss 85
MONDO:0013269	label	autosomal recessive nonsyndromic deafness 91	autosomal recessive nonsyndromic hearing loss 91
MONDO:0013305	label	autosomal dominant nonsyndromic deafness 51	autosomal dominant nonsyndromic hearing loss 51
MONDO:0013365	label	autosomal recessive nonsyndromic deafness 83	autosomal recessive nonsyndromic hearing loss 83
MONDO:0013386	label	autosomal recessive nonsyndromic deafness 74	autosomal recessive nonsyndromic hearing loss 74
MONDO:0013471	label	autosomal recessive nonsyndromic deafness 61	autosomal recessive nonsyndromic hearing loss 61
MONDO:0013489	label	autosomal recessive nonsyndromic deafness 89	autosomal recessive nonsyndromic hearing loss 89
MONDO:0013537	label	autosomal recessive nonsyndromic deafness 29	autosomal recessive nonsyndromic hearing loss 29
MONDO:0013593	label	autosomal dominant nonsyndromic deafness 64	autosomal dominant nonsyndromic hearing loss 64
MONDO:0019299	label	unclassified genetic skin disorder	obsolete unclassified genetic skin disorder
MONDO:0013632	label	autosomal dominant nonsyndromic deafness 33	autosomal dominant nonsyndromic hearing loss 33
MONDO:0013738	label	autosomal recessive nonsyndromic deafness 96	autosomal recessive nonsyndromic hearing loss 96
MONDO:0013823	label	autosomal dominant nonsyndromic deafness 4B	autosomal dominant nonsyndromic hearing loss 4B
MONDO:0013826	label	autosomal recessive nonsyndromic deafness 86	autosomal recessive nonsyndromic hearing loss 86
MONDO:0700075	label	congenital muscular dystrophy caused by varation in POMGNT2	congenital muscular dystrophy caused by variation in POMGNT2
MONDO:0013929	label	autosomal recessive nonsyndromic deafness 98	autosomal recessive nonsyndromic hearing loss 98
MONDO:0013963	label	autosomal recessive nonsyndromic deafness 93	autosomal recessive nonsyndromic hearing loss 93
MONDO:0013978	label	autosomal recessive nonsyndromic deafness 70	autosomal recessive nonsyndromic hearing loss 70
MONDO:0013984	label	autosomal recessive nonsyndromic deafness 84B	autosomal recessive nonsyndromic hearing loss 84B
MONDO:0013985	label	autosomal recessive nonsyndromic deafness 18B	autosomal recessive nonsyndromic hearing loss 18B
MONDO:0700084	label	myopathy caused by varation in GMPPB	myopathy caused by variation in GMPPB
MONDO:0014182	label	autosomal recessive nonsyndromic deafness 88	autosomal recessive nonsyndromic hearing loss 88
MONDO:0014237	label	autosomal recessive nonsyndromic deafness 76	autosomal recessive nonsyndromic hearing loss 76
MONDO:0014283	label	autosomal dominant nonsyndromic deafness 56	autosomal dominant nonsyndromic hearing loss 56
MONDO:0014291	label	autosomal dominant nonsyndromic deafness 54	autosomal dominant nonsyndromic hearing loss 54
MONDO:0014293	label	autosomal dominant nonsyndromic deafness 58	autosomal dominant nonsyndromic hearing loss 58
MONDO:0014353	label	PGM3-CDG	immunodeficiency 23
MONDO:0014363	label	autosomal recessive nonsyndromic deafness 101	autosomal recessive nonsyndromic hearing loss 101
MONDO:0014428	label	autosomal recessive nonsyndromic deafness 102	autosomal recessive nonsyndromic hearing loss 102
MONDO:0014469	label	autosomal recessive nonsyndromic deafness 103	autosomal recessive nonsyndromic hearing loss 103
MONDO:0014470	label	autosomal dominant nonsyndromic deafness 65	autosomal dominant nonsyndromic hearing loss 65
MONDO:0014594	label	autosomal dominant nonsyndromic deafness 67	autosomal dominant nonsyndromic hearing loss 67
MONDO:0014603	label	autosomal dominant nonsyndromic deafness 40	autosomal dominant nonsyndromic hearing loss 40
MONDO:0014675	label	autosomal recessive nonsyndromic deafness 104	autosomal recessive nonsyndromic hearing loss 104
MONDO:0014738	label	autosomal dominant nonsyndromic deafness 69	autosomal dominant nonsyndromic hearing loss 69
MONDO:0014739	label	autosomal recessive nonsyndromic deafness 97	autosomal recessive nonsyndromic hearing loss 97
MONDO:0014740	label	autosomal dominant nonsyndromic deafness 68	autosomal dominant nonsyndromic hearing loss 68
MONDO:0014853	label	autosomal dominant nonsyndromic deafness 70	autosomal dominant nonsyndromic hearing loss 70
MONDO:0014854	label	autosomal dominant nonsyndromic deafness 66	autosomal dominant nonsyndromic hearing loss 66
MONDO:0015192	label	unclassified intestinal pseudoobstruction	obsolete unclassified intestinal pseudoobstruction
MONDO:0019497	label	nonsyndromic genetic deafness	nonsyndromic genetic hearing loss
MONDO:0016538	label	hypotonia-cystinuria syndrome type 1	obsolete hypotonia-cystinuria syndrome type 1
MONDO:0016665	label	unclassified vasculitis	obsolete unclassified vasculitis
MONDO:0016886	label	partial deletion of the short arm of chromosome 4	obsolete partial deletion of the short arm of chromosome 4
MONDO:0016891	label	partial deletion of the short arm of chromosome 9	obsolete partial deletion of the short arm of chromosome 9
MONDO:0016895	label	partial monosomy of the short arm of chromosome 17	obsolete partial monosomy of the short arm of chromosome 17
MONDO:0016920	label	partial deletion of the long arm of chromosome 22	obsolete partial deletion of the long arm of chromosome 22
MONDO:0017608	label	dystrophic epidermolysis bullosa	obsolete dystrophic epidermolysis bullosa
MONDO:0018138	label	ocular albinism with congenital sensorineural deafness	ocular albinism with congenital sensorineural hearing loss
MONDO:0018139	label	scleredema	obsolete scleredema
MONDO:0018348	label	polyglucosan body myopathy type 1	obsolete polyglucosan body myopathy type 1
MONDO:0018355	label	Prader-Willi-like syndrome due to point mutation	SIM1-related Prader-Willi-like syndrome
MONDO:0018466	label	hereditary late onset Parkinson disease	obsolete hereditary late onset Parkinson disease
MONDO:0019302	label	mucopolysaccharidosis with skin involvement	obsolete mucopolysaccharidosis with skin involvement
MONDO:0020241	label	unclassified familial retinal dystrophy	obsolete unclassified familial retinal dystrophy
MONDO:0020313	label	unclassified myelodysplastic/myeloproliferative disease	obsolete unclassified myelodysplastic/myeloproliferative disease
MONDO:0020315	label	unclassified myelodysplastic syndrome	obsolete unclassified myelodysplastic syndrome
MONDO:0020682	label	Ehlers-Danlos syndrome, progeroid type 1	Ehlers-Danlos syndrome, spondylodysplastic type, 1
MONDO:0020752	label	EJM1	myoclonic epilepsy, juvenile, susceptibility to, 1
MONDO:0024429	label	Alice in wonderland syndrome	Alice in Wonderland syndrome
MONDO:0029137	label	deafness, autosomal dominant 74	hearing loss, autosomal dominant 74
MONDO:0029142	label	deafness, autosomal recessive 111	hearing loss, autosomal recessive 111
MONDO:0030058	label	deafness, autosomal dominant 77	hearing loss, autosomal dominant 77
MONDO:0030905	label	deafness, autosomal recessive 117	hearing loss, autosomal recessive 117
MONDO:0030998	label	deafness, autosomal dominant 80	hearing loss, autosomal dominant 80
MONDO:0032639	label	deafness, autosomal recessive 112	hearing loss, autosomal recessive 112
MONDO:0032732	label	deafness, autosomal recessive 113	hearing loss, autosomal recessive 113
MONDO:0032740	label	deafness, autosomal recessive 100	hearing loss, autosomal recessive 100
MONDO:0032749	label	deafness, autosomal recessive 94	hearing loss, autosomal recessive 94
MONDO:0032761	label	deafness, autosomal recessive 114	hearing loss, autosomal recessive 114
MONDO:0032762	label	deafness, autosomal recessive 115	hearing loss, autosomal recessive 115
MONDO:0032776	label	deafness, autosomal recessive 99	hearing loss, autosomal recessive 99
MONDO:0032802	label	deafness, autosomal dominant 37	hearing loss, autosomal dominant 37
MONDO:0032911	label	deafness, autosomal dominant 75	hearing loss, autosomal dominant 75
MONDO:0032917	label	deafness, autosomal dominant 76	hearing loss, autosomal dominant 76
MONDO:0033198	label	deafness, autosomal recessive 106	hearing loss, autosomal recessive 106
MONDO:0033199	label	deafness, autosomal recessive 107	hearing loss, autosomal recessive 107
MONDO:0033200	label	deafness, autosomal recessive 108	hearing loss, autosomal recessive 108
MONDO:0033201	label	deafness, autosomal recessive 57	hearing loss, autosomal recessive 57
MONDO:0033202	label	deafness, autosomal recessive 109	hearing loss, autosomal recessive 109
MONDO:0033258	label	deafness, autosomal dominant 71	hearing loss, autosomal dominant 71
MONDO:0033259	label	deafness, autosomal dominant 72	hearing loss, autosomal dominant 72
MONDO:0033260	label	deafness, autosomal dominant 73	hearing loss, autosomal dominant 73
MONDO:0033261	label	deafness, autosomal dominant 34, with or without inflammation	hearing loss, autosomal dominant 34, with or without inflammation
MONDO:0033665	label	deafness, autosomal dominant 78	hearing loss, autosomal dominant 78
MONDO:0033668	label	deafness, autosomal dominant 79	hearing loss, autosomal dominant 79
MONDO:0033670	label	deafness, autosomal recessive 116	hearing loss, autosomal recessive 116
MONDO:0035398	label	hypomyelination of early myelinating structures	obsolete hypomyelination of early myelinating structures
MONDO:0054860	label	deafness, autosomal recessive 110	hearing loss, autosomal recessive 110
MONDO:0700069	label	myopathy caused by varation in POMGNT2	myopathy caused by variation in POMGNT2
MONDO:0700066	definition	Any myopathy in which the cause of the disease is a varation in the FKRP gene.	Any myopathy in which the cause of the disease is a variation in the FKRP gene.
MONDO:0700068	definition	Any myopathy in which the cause of the disease is a varation in the POMGNT1 gene.	Any myopathy in which the cause of the disease is a variation in the POMGNT1 gene.
MONDO:0000881	definition	A group of rare myeloid and lymphoid neoplasms characterized by rearrangement of the PDGFRA, PDGFRB, or FGFR1 genes, resulting in the formation of fusion transcripts and aberrant tyrosine kinase activity. Eosinophilia is a characteristic finding but it is not always present. This group includes the myeloid and lymphoid neoplasms with t(8;9)(p22;p24.1);PCM1-JAK2 as a provisional entity.	
MONDO:0000882	definition	Hematologic neoplasms characterized by the rearrangement of the PDGFRA gene, most often resulting in the formation of FIP1L1-PDGFRA fusion transcripts. Patients usually present with chronic eosinophilic leukemia, and less often with acute myeloid leukemia or T-lymphoblastic leukemia.	
MONDO:0000883	definition	Myeloid and rarely lymphoid neoplasms characterized by the rearrangement of the PDGFRB gene, most often resulting in the formation of ETV6-PDGFRB fusion transcripts. Patients usually present with chronic myelomonocytic leukemia and less often with atypical chronic myeloid leukemia, or chronic eosinophilic leukemia.	
MONDO:0017884	definition	Papillary renal cell carcinoma is a rare subtype of renal cell carcinoma, arising from the renal tubular epithelium and showing a papillary growth pattern, which typically manifests with hematuria, flank pain, palpable abdominal mass or nonspecific symptoms, such as fatigue, weight loss or fever. Symptoms related to metastatic spread, such as bone pain or persistent cough, are frequently associated since early diagnosis is not common. It is typically multifocal, bilateral, and in most cases sporadic, although different hereditary syndromes, such as Hereditary leiomyoma renal cell carcinoma, Birt-Hogg-DubC) syndrome and Tuberous sclerosis, may predispose to the development of papillary renal cell carcinoma.	A rare subtype of renal cell carcinoma, arising from the renal tubular epithelium and showing a papillary growth pattern, which typically manifests with hematuria, flank pain, palpable abdominal mass or nonspecific symptoms, such as fatigue, weight loss or fever. Symptoms related to metastatic spread, such as bone pain or persistent cough, are frequently associated since early diagnosis is not common. It is typically multifocal, bilateral, and in most cases sporadic, although different hereditary syndromes, such as Hereditary leiomyoma renal cell carcinoma, Birt-Hogg-DubC) syndrome and Tuberous sclerosis, may predispose to the development of papillary renal cell carcinoma.
MONDO:0015993	definition	Cone rod dystrophies (CRDs) are inherited retinal dystrophies that belong to the group of pigmentary retinopathies.	Inherited retinal dystrophies that belong to the group of pigmentary retinopathies.
MONDO:0019625	definition	Familial thoracic aortic aneurysm and aortic dissection is a rare genetic vascular disease characterized by the familial occurrence of thoracic aortic aneurysm, dissection or dilatation affecting one or more aortic segments (aortic root, ascending aorta, arch or descending aorta) in the absence of any other associated disease. Depending on the size, location and progression rate of dilatation/dissection, patients may be asymptomatic or may present dyspnea, cough, jaw, neck, chest or back pain, head, neck or upper limb edema, difficulty swallowing, voice hoarseness, pale skin, faint pulse and/or numbness/tingling in limbs. Patients have increased risk of presenting life threatening aortic rupture.	A rare genetic vascular disease characterized by the familial occurrence of thoracic aortic aneurysm, dissection or dilatation affecting one or more aortic segments (aortic root, ascending aorta, arch or descending aorta) in the absence of any other associated disease. Depending on the size, location and progression rate of dilatation/dissection, patients may be asymptomatic or may present dyspnea, cough, jaw, neck, chest or back pain, head, neck or upper limb edema, difficulty swallowing, voice hoarseness, pale skin, faint pulse and/or numbness/tingling in limbs. Patients have increased risk of presenting life threatening aortic rupture.
MONDO:0007570	definition	Erythema palmare hereditarium is a rare, benign, congenital genetic skin disorder characterized by permanent and asymptomatic erythema of the palmar and, less frequently, the solar surfaces. In most cases, it presents with sharply demarcated redness of the thenar and hypothenar eminences, as well as the palmar aspect of the phalanges, with scattered telangiectasia spots that do not cause any discomfort (pain, itching or burning) to the patient.	A rare, benign, congenital genetic skin disorder characterized by permanent and asymptomatic erythema of the palmar and, less frequently, the solar surfaces. In most cases, it presents with sharply demarcated redness of the thenar and hypothenar eminences, as well as the palmar aspect of the phalanges, with scattered telangiectasia spots that do not cause any discomfort (pain, itching or burning) to the patient.
MONDO:0016028	definition	Erythromelalgia is a rare neurovascular peripheral pain disorder due to the intermittent blockage of the blood vessels, usually in the lower extremities or hands. This causes hyperemia and inflammation at the origin of burning pain and skin redness. The attacks are periodic and are commonly triggered by heat, pressure, mild activity, exertion, insomnia or stress. Erythromelalgia may occur either as a primary or secondary disorder. Primary erythromelalgia is caused by gene mutations. Secondary erythromelalgia can result from small fiber peripheral neuropathy of any cause, essential thrombocytemia, hypercholesterolemia, mushroom or mercury poisoning, and some autoimmune disorders.	A rare neurovascular peripheral pain disorder due to the intermittent blockage of the blood vessels, usually in the lower extremities or hands. This causes hyperemia and inflammation at the origin of burning pain and skin redness. The attacks are periodic and are commonly triggered by heat, pressure, mild activity, exertion, insomnia or stress. Erythromelalgia may occur either as a primary or secondary disorder. Primary erythromelalgia is caused by gene mutations. Secondary erythromelalgia can result from small fiber peripheral neuropathy of any cause, essential thrombocytemia, hypercholesterolemia, mushroom or mercury poisoning, and some autoimmune disorders.
MONDO:0007600	definition	Fanconi syndrome is a condition in which the kidneys do not absorb certain substances into the body. These substances, such as cysteine, fructose, galactose, or glycogen, are lost in the urine. Fanconi syndrome is thought to be caused by genetic and environmental factors, and it may be diagnosed at any age. Symptoms of Fanconi syndrome include increased urine production (which may cause dehydration), weakness, and abnormalities of the bones.	A condition in which the kidneys do not absorb certain substances into the body. These substances, such as cysteine, fructose, galactose, or glycogen, are lost in the urine. Fanconi syndrome is thought to be caused by genetic and environmental factors, and it may be diagnosed at any age. Symptoms of Fanconi syndrome include increased urine production (which may cause dehydration), weakness, and abnormalities of the bones.
MONDO:0007691	definition	A chronic monophasic, progressive or relapsing symmetric sensorimotor disorder characterized by progressive muscular weakness with impaired sensation, absent or diminished tendon reflexes and elevated cerebrospinal fluid (CSF) proteins.	A form of Guillain-Barre syndrome (GBS) that occurs in persons or families with a genetic predisposition to the acute or chronic forms of GBS. Note that GBS is considered to be a complex multifactorial disorder with both genetic and environmental factors, and families with clear Mendelian inheritance have been rarely reported: a mutation in the PMP22 gene (601097) on chromosome 17 was identified in a single family with the acute (AIDP) and chronic (CIDP) forms of inflammatory demyelinating polyneuropathy.
MONDO:0007935	definition	Cystoid macular dystrophy is an autosomal dominantly inherited cystoid macular edema manifesting with macular atrophy, strabismus and, sometimes, pericentral retinitis pigmentosa. It is associated with a poor visual prognosis.	An autosomal dominantly inherited cystoid macular edema manifesting with macular atrophy, strabismus and, sometimes, pericentral retinitis pigmentosa. It is associated with a poor visual prognosis.
MONDO:0018868	definition	Metachromatic leukodystrophy (MLD) is a rare lysosomal storage disorder characterized byintralysosomal accumulation of sulfatides in various tissues, leading to progressive deterioration of motor and neurocognitive function.	A rare lysosomal storage disorder characterized byintralysosomal accumulation of sulfatides in various tissues, leading to progressive deterioration of motor and neurocognitive function.
MONDO:0009723	definition	Leigh syndrome or subacute necrotizing encephalomyelopathy is a progressive neurological disease defined by specific neuropathological features associating brainstem and basal ganglia lesions.	A progressive neurological disease defined by specific neuropathological features associating brainstem and basal ganglia lesions.
MONDO:0019260	definition	Adult neuronal ceroid lipofuscinoses (ANCLs) are a genetically heterogeneous group of neuronal ceroid lipofuscinoses (NCLs) with onset during the third decade of life, characterized by dementia, seizures and loss of motor capacities, and sometimes associated with visual loss caused by retinal degeneration.	A genetically heterogeneous group of neuronal ceroid lipofuscinoses (NCLs) with onset during the third decade of life, characterized by dementia, seizures and loss of motor capacities, and sometimes associated with visual loss caused by retinal degeneration.
MONDO:0016620	definition	Primary hypertrophic osteoarthropathy (PHO) is a genetically and clinically heterogeneous inherited disorder characterized by digital clubbing and osteoarthropathy, with variable features of pachydermia, delayed closure of the fontanels, and congenital heart disease. There are two types of PHO: pachydermoperiostosis and cranio-osteoarthropathy.	A genetically and clinically heterogeneous inherited disorder characterized by digital clubbing and osteoarthropathy, with variable features of pachydermia, delayed closure of the fontanels, and congenital heart disease. There are two types of PHO: pachydermoperiostosis and cranio-osteoarthropathy.
MONDO:0020381	definition	Butterfly-shaped pigment dystrophy is a patterned dystrophy of the retinal pigment epithelium characterized by abnormal accumulation of lipofuscin in a butterfly-shaped distribution at the retinal pigment epithelium level. Patients manifest with a slowly progressive loss of vision that often only becomes apparent in old age.	A macular degeneration characterized by abnormal accumulation of lipofuscin in the retinal pigment epithelium in a distinct pattern, patterns include; reticular ('fishnet-like'), macroreticular ('spider-shaped'), and butterfly-shaped.
MONDO:0019188	definition	Rubinstein-Taybi syndrome is a rare malformation syndrome characterized by congenital anomalies (microcephaly, specific facial characteristics, broad thumbs and halluces and postnatal growth retardation), short stature, intellectual disability and behavioural characteristics.	A rare malformation syndrome characterized by congenital anomalies (microcephaly, specific facial characteristics, broad thumbs and halluces and postnatal growth retardation), short stature, intellectual disability and behavioural characteristics.
MONDO:0008492	definition	Stiff skin syndrome (SSS) is a rare syndrome characterized by hard, thick skin, usually on the entire body. The thickening of the skin can limit joint mobility and causes joints to be stuck in a bent position (flexion contractures). The onset of signs and symptoms can range from presenting at birth through childhood. Other signs and symptoms may include excessive hair growth (hypertrichosis), loss of body fat (lipodystrophy), scoliosis, muscle weakness, slow growth, and short stature. Weakness or paralysis of the eye muscles have also been reported. Stiff skin syndrome is caused by mutations (changes) in the FBN1 gene and is inherited in an autosomal dominant manner. Diagnosis is based on a clinical evaluation that is consistent with stiff skin syndrome, and the diagnosis can be confirmed with genetic testing. Treatment is based on the symptoms of each individual and may include physical therapy.	A rare syndrome characterized by hard, thick skin, usually on the entire body. The thickening of the skin can limit joint mobility and causes joints to be stuck in a bent position (flexion contractures). The onset of signs and symptoms can range from presenting at birth through childhood. Other signs and symptoms may include excessive hair growth (hypertrichosis), loss of body fat (lipodystrophy), scoliosis, muscle weakness, slow growth, and short stature. Weakness or paralysis of the eye muscles have also been reported. Stiff skin syndrome is caused by mutations (changes) in the FBN1 gene and is inherited in an autosomal dominant manner. Diagnosis is based on a clinical evaluation that is consistent with stiff skin syndrome, and the diagnosis can be confirmed with genetic testing. Treatment is based on the symptoms of each individual and may include physical therapy.
MONDO:0008585	definition	HELLP syndrome is a life-threatening condition that can potentially complicate pregnancy. It is named for 3 features of the condition: H emolysis, E levated L iver enzyme levels, and L ow P latelet levels. It typically occurs in the last 3 months of pregnancy (the third trimester) but can also start soon after delivery. A wide range of non-specific symptoms may be present in women with HELLP syndrome. Symptoms may include fatigue; malaise; fluid retention and excess weight gain; headache; nausea and vomiting; pain in the upper right or middle of the abdomen; blurry vision; and rarely, nosebleed or seizures. The cause of HELLP syndrome is not known, but certain risk factors have been associated with the condition. It is most common in women with preeclampsia or eclampsia. If not diagnosed and treated quickly, HELLP syndrome can lead to serious complications for the mother and baby.The main treatment is to deliver the baby as soon as possible, even if premature. Treatment may also includemedications needed for the mother or baby, and blood transfusion for severe bleeding problems.	A life-threatening condition that can potentially complicate pregnancy. It is named for 3 features of the condition: H emolysis, E levated L iver enzyme levels, and L ow P latelet levels. It typically occurs in the last 3 months of pregnancy (the third trimester) but can also start soon after delivery. A wide range of non-specific symptoms may be present in women with HELLP syndrome. Symptoms may include fatigue; malaise; fluid retention and excess weight gain; headache; nausea and vomiting; pain in the upper right or middle of the abdomen; blurry vision; and rarely, nosebleed or seizures. The cause of HELLP syndrome is not known, but certain risk factors have been associated with the condition. It is most common in women with preeclampsia or eclampsia. If not diagnosed and treated quickly, HELLP syndrome can lead to serious complications for the mother and baby.The main treatment is to deliver the baby as soon as possible, even if premature. Treatment may also include medications needed for the mother or baby, and blood transfusion for severe bleeding problems.
MONDO:0019635	definition	Idiopathic achalasia (IA) is a primary esophageal motor disorder characterized by loss of esophageal peristalsis and insufficient lower esophageal sphincter (LES) relaxation in response to deglutition.	A primary esophageal motor disorder characterized by loss of esophageal peristalsis and insufficient lower esophageal sphincter (LES) relaxation in response to deglutition.
MONDO:0016295	definition	Neuronal ceroid lipofuscinoses (NCLs) are a group of inherited progressive degenerative brain diseases characterized clinically by a decline of mental and other capacities, epilepsy, and vision loss through retinal degeneration, and histopathologically by intracellular accumulation of an autofluorescent material, ceroid lipofuscin, in the neuronal cells in the brain and in the retina.	A group of inherited progressive degenerative brain diseases characterized clinically by a decline of mental and other capacities, epilepsy, and vision loss through retinal degeneration, and histopathologically by intracellular accumulation of an autofluorescent material, ceroid lipofuscin, in the neuronal cells in the brain and in the retina.
MONDO:0019262	definition	Juvenile neuronal ceroid lipofuscinoses (JNCLs) are a genetically heterogeneous group of neuronal ceroid lipofuscinoses (NCLs) typically characterized by onset at early school age with vision loss due to retinopathy, seizures and the decline of mental and motor capacities.	A genetically heterogeneous group of neuronal ceroid lipofuscinoses (NCLs) typically characterized by onset at early school age with vision loss due to retinopathy, seizures and the decline of mental and motor capacities.
MONDO:0015674	definition	Late infantile neuronal ceroid lipofuscinoses (LINCLs) are a genetically heterogeneous group of neuronal ceroid lipofuscinoses (NCLs) typically characterized by onset during infancy or early childhood with decline of mental and motor capacities, epilepsy, and vision loss through retinal degeneration.	A genetically heterogeneous group of neuronal ceroid lipofuscinoses (NCLs) typically characterized by onset during infancy or early childhood with decline of mental and motor capacities, epilepsy, and vision loss through retinal degeneration.
MONDO:0015229	definition	Bardet-Biedl syndrome (BBS) is a ciliopathy with multisystem involvement. It is invariantly characterized by rod-cone dystrophy, and at least three additional non-ocular features such as intellectual disability, obesity, polydactyly, hypogonadism, or renal anomalies as primary manifestations. In the absence of one of these four primary clinical features, the diagnosis of BBS is made when at least two secondary features are observed, including hepatic fibrosis, diabetes mellitus, reproductive and developmental abnormalities, growth retardation, speech delays, or cardiovascular problems	A ciliopathy with multisystem involvement. It is invariantly characterized by rod-cone dystrophy, and at least three additional non-ocular features such as intellectual disability, obesity, polydactyly, hypogonadism, or renal anomalies as primary manifestations. In the absence of one of these four primary clinical features, the diagnosis of BBS is made when at least two secondary features are observed, including hepatic fibrosis, diabetes mellitus, reproductive and developmental abnormalities, growth retardation, speech delays, or cardiovascular problems
MONDO:0008956	definition	Congenital neuronal ceroid lipofuscinosis (CNCL) is a severe form of neuronal ceroid lipofuscinosis (NCL) with onset at birth characterized by primary microcephaly, neonatal epilepsy, and death in early infancy.	
MONDO:0008960	definition	Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome is a rare demyelinating hereditary motor and sensory neuropathy characterized by early-onset, slowly progressive, distal muscular weakness and atrophy with no sensory impairment, congenital sensorineural deafness and mild intellectual disability (with absence of normal speech development). The absence of large myelinated fibers on sural nerve biopsy is equally characteristic of the disease.	A rare demyelinating hereditary motor and sensory neuropathy characterized by early-onset, slowly progressive, distal muscular weakness and atrophy with no sensory impairment, congenital sensorineural deafness and mild intellectual disability (with absence of normal speech development). The absence of large myelinated fibers on sural nerve biopsy is equally characteristic of the disease.
MONDO:0009198	definition	Congenital lethal erythroderma is a rare skin disorder characterized by erythrodermic, peeling skin from birth with no obvious nail or hair-shaft abnormalities and other associated anomalies including diarrhea, failure to thrive and severe hypoalbuminaemia resistant to correction by enteral or intravenous supplementation. An autosomal recessive mode of inheritance is highly probable. The prognosis is poor and infants die in the first months of life. There have been no further descriptions in the literature since 1992.	A rare skin disorder characterized by erythrodermic, peeling skin from birth with no obvious nail or hair-shaft abnormalities and other associated anomalies including diarrhea, failure to thrive and severe hypoalbuminaemia resistant to correction by enteral or intravenous supplementation. An autosomal recessive mode of inheritance is highly probable. The prognosis is poor and infants die in the first months of life. There have been no further descriptions in the literature since 1992.
MONDO:0009218	definition	Farber disease is a rare sphingolipid disorder characterized by a spectrum of clinical signs ranging from the classical triad of painful and progressively deformed joints, subcutaneous nodules, and progressive hoarseness (due to laryngeal involvement) that presents in infancy, to varying phenotypes with respiratory and neurologic involvement.	A rare sphingolipid disorder characterized by a spectrum of clinical signs ranging from the classical triad of painful and progressively deformed joints, subcutaneous nodules, and progressive hoarseness (due to laryngeal involvement) that presents in infancy, to varying phenotypes with respiratory and neurologic involvement.
MONDO:0018149	definition	GM1 gangliosidosis is a rare lysosomal storage disorder characterized biochemically by deficient beta-galactosidase activity and clinically by a wide range of variable neurovisceral, ophthalmological and dysmorphic features.	A rare lysosomal storage disorder characterized biochemically by deficient beta-galactosidase activity and clinically by a wide range of variable neurovisceral, ophthalmological and dysmorphic features.
MONDO:0009342	definition	Hirschsprung disease-deafness-polydactyly is an extremely rare malformative association, described in only two siblings to date, and characterized by Hirschsprung disease (defined by the presence of an aganglionic segment of variable extent in the terminal part of the colon that leads to the symptoms of intestinal obstruction including constipation and abdominal distension), polydactyly of hands and/or feet, unilateral renal agenesis, hypertelorism and congenital deafness. There have been no further descriptions in the literature since 1988.	An extremely rare malformative association, described in only two siblings to date, and characterized by Hirschsprung disease (defined by the presence of an aganglionic segment of variable extent in the terminal part of the colon that leads to the symptoms of intestinal obstruction including constipation and abdominal distension), polydactyly of hands and/or feet, unilateral renal agenesis, hypertelorism and congenital deafness. There have been no further descriptions in the literature since 1988.
MONDO:0700070	definition	Any myopathy in which the cause of the disease is a varation in the POMT1 gene.	Any myopathy in which the cause of the disease is a variation in the POMT1 gene.
MONDO:0009465	definition	Multiple intestinal atresia is a rare form of intestinal atresia characterized by the presence of numerous atresic segments in the small bowel (duodenum) or large bowel and leading to symptoms of intestinal obstruction: vomiting, abdominal bloating and inability to pass meconium in newborns.	A rare form of intestinal atresia characterized by the presence of numerous atresic segments in the small bowel (duodenum) or large bowel and leading to symptoms of intestinal obstruction: vomiting, abdominal bloating and inability to pass meconium in newborns.
MONDO:0009499	definition	Krabbe disease is a lysosomal disorder that affects the white matter of the central and peripheral nervous systems. It includes infantile, late-infantile/juvenile and adult forms.	A lysosomal disorder that affects the white matter of the central and peripheral nervous systems. It includes infantile, late-infantile/juvenile and adult forms.
MONDO:0009514	definition	Laurence-Moon syndrome (LMS) is a very rare genetic multisystemic disorder characterized by pituitary dysfunction, ataxia, peripheral neuropathy, spastic paraplegia, and chorioretinal dystrophy.	A very rare genetic multisystemic disorder characterized by pituitary dysfunction, ataxia, peripheral neuropathy, spastic paraplegia, and chorioretinal dystrophy.
MONDO:0009653	definition	Mucolipidosis type IV (ML IV) is a lysosomal storage disease characterised clinically by psychomotor retardation and visual abnormalities including corneal clouding, retinal degeneration, or strabismus.	A lysosomal storage disease characterised clinically by psychomotor retardation and visual abnormalities including corneal clouding, retinal degeneration, or strabismus.
MONDO:0700067	definition	Any myopathy in which the cause of the disease is a varation in the FKTN gene.	Any myopathy in which the cause of the disease is a variation in the FKTN gene.
MONDO:0009737	definition	Galactosialidosis is a lysosomal storage disease characterized by coarse facial features, macular ''cherry red spot'', and dysostosis multiplex. Clinical presentation can be heterogenous ranging from a severe, early-onset, rapidly progressive infantile form to late onset, slowly progressive juvenile/adult form.	A lysosomal storage disease characterized by coarse facial features, macular ''cherry red spot'', and dysostosis multiplex. Clinical presentation can be heterogenous ranging from a severe, early-onset, rapidly progressive infantile form to late onset, slowly progressive juvenile/adult form.
MONDO:0009796	definition	Gyrate atrophy of the choroid and retina (GACR) is a very rare, inherited retinal dystrophy, characterized by progressive chorioretinal atrophy, myopia and early cataract.	A very rare inherited retinal dystrophy characterized by progressive chorioretinal atrophy, myopia and early cataract.
MONDO:0010031	definition	SjC6gren-Larsson syndrome (SLS) is a neurocutaneous disorder caused by an inborn error of lipid metabolism and characterized by congenital ichthyosis, intellectual deficit, and spasticity.	A neurocutaneous disorder caused by an inborn error of lipid metabolism and characterized by congenital ichthyosis, intellectual deficit, and spasticity.
MONDO:0019501	definition	Usher syndrome (US) is characterized by the association of sensorineural deafness (usually congenital) with retinitis pigmentosa and progressive vision loss.	A syndromic diseae characterized by the association of sensorineural deafness (usually congenital) with retinitis pigmentosa and progressive vision loss.
MONDO:0016535	definition	Hypohidrotic ectodermal dysplasia (HED) is a genetic disorder of ectoderm development characterized by malformation of ectodermal structures such as skin, hair, teeth and sweat glands. It comprises three clinically almost indistinguishable subtypes with impaired sweating as the key symptom: Christ-Siemens-Touraine (CST) syndrome (X-linked), autosomal recessive (AR), and autosomal dominant (AD) HED, as well as a fourth rare subtype with immunodeficiency as the key symptom (HED with immunodeficiency).	A genetic disorder of ectoderm development characterized by malformation of ectodermal structures such as skin, hair, teeth and sweat glands. It comprises three clinically almost indistinguishable subtypes with impaired sweating as the key symptom: Christ-Siemens-Touraine (CST) syndrome (X-linked), autosomal recessive (AR), and autosomal dominant (AD) HED, as well as a fourth rare subtype with immunodeficiency as the key symptom (HED with immunodeficiency).
MONDO:0010403	definition	Albinism-deafness syndrome (ADFN) is characterised by congenital nerve deafness and piebaldness with no ocular albinism. It has been described in one large pedigree. Transmission is X-linked with affected males presenting with profound sensorineural deafness and severe pigmentary abnormalities of the skin, and carrier females presenting with variable hearing impairment without any pigmentary changes. The causative gene has been mapped to Xq26.3-q27.1.	A syndromic genetic hearing loss is characterised by congenital nerve deafness and piebaldness with no ocular albinism. It has been described in one large pedigree. Transmission is X-linked with affected males presenting with profound sensorineural deafness and severe pigmentary abnormalities of the skin, and carrier females presenting with variable hearing impairment without any pigmentary changes. The causative gene has been mapped to Xq26.3-q27.1.
MONDO:0010527	definition	Microphthalmia-ankyloblepharon-intellectual disability syndrome is characterized by microphthalmia, ankyloblepharon and intellectual deficit. It has been described in seven male patients from two generations of a Northern Ireland family. The causative gene is localized to the Xq27-q28 region. The syndrome is transmitted as an X-linked recessive trait.	
MONDO:0018904	definition	Membranoproliferative glomerulonephritis (MPGN) is a chronic progressive kidney disorder characterized by glomerular capillary wall structural changes and mesangial cell proliferation leading to nephrotic syndrome, hypocomplementemia, hypertension, proteinuria and end-stage kidney disease. MPGN can be due to either idiopathic (type 1, 2 and 3 MPGN) or secondary (associated with infectious and immune complex diseases) causes.	A rare glomerular disease characterized by a pattern of glomerular injury on kidney biopsy with characteristic light microscopic changes: mesangial hypercellularity, endocapillary proliferation, and thickening of the glomerular basement membrane (GBM). On the basis of immunofluorescence (IF) the disorder is divided into C3 glomerulopathy (C3G) or immunoglobulin-mediated membranoproliferative glomerulonephritis. Through electron microscopy C3G is further divided into Dense deposit disease, with highly electrondense deposits in the glomerular basement membrane, and C3 glomerulonephritis, with mesangial, intramembranous, subendothelial and subepithelial deposits. Secondary causes (autoimmune, infectious, malignancies) are excluded.
MONDO:0010674	definition	Mucopolysaccharidosis type 2 (MPS2) is a lysosomal storage disease leading to a massive accumulation of glycosaminoglycans and a wide variety of symptoms including distinctive coarse facial features, short stature, cardio-respiratory involvement and skeletal abnormalities. It manifests as a continuum varying from a severe to an attenuated form without neuronal involvement.	A lysosomal storage disease leading to a massive accumulation of glycosaminoglycans and a wide variety of symptoms including distinctive coarse facial features, short stature, cardio-respiratory involvement and skeletal abnormalities. It manifests as a continuum varying from a severe to an attenuated form without neuronal involvement.
MONDO:0010725	definition	X-linked retinoschisis (XLRS) is a genetic ocular disease that is characterized by reduced visual acuity in males due to juvenile macular degeneration.	A genetic ocular disease that is characterized by reduced visual acuity in males due to juvenile macular degeneration.
MONDO:0011107	definition	Hypotrichosis with juvenile macular degeneration (HJMD) is a very rare syndrome characterized by sparse and short hair from birth followed by progressive macular degeneration leading to blindness.	A very rare syndrome characterized by sparse and short hair from birth followed by progressive macular degeneration leading to blindness.
MONDO:0011144	definition	Neuronal ceroid lipofuscinosis 6 (CLN6-NCL) is a rare condition that affects the nervous system. Signs and symptoms of the condition generally develop between ages 18 months and 8 years, although later onset cases have been reported. Affected people may experience loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and developmental regression (loss of previously acquired skills). It occurs predominantly in people of Portuguese, Indian, Pakistani, or Czech ancestry. CLN6-NCL is caused by changes (mutations) in the CLN6 gene and is inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms.	A rare condition that affects the nervous system. Signs and symptoms of the condition generally develop between ages 18 months and 8 years, although later onset cases have been reported. Affected people may experience loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and developmental regression (loss of previously acquired skills). It occurs predominantly in people of Portuguese, Indian, Pakistani, or Czech ancestry. CLN6-NCL is caused by changes (mutations) in the CLN6 gene and is inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms.
MONDO:0011329	definition	Any spastic quadriplegia in which the cause of the disease is a mutation in the GAD1 gene.	
MONDO:0011462	definition	Pyogenic arthritis-pyoderma gangrenosum-acne syndrome is a rare pleiotropic autoinflammatory disorder of childhood, primarily affecting the joints and skin.	A rare pleiotropic autoinflammatory disorder of childhood, primarily affecting the joints and skin.
MONDO:0011781	definition	Spinocerebellar ataxia type 17 (SCA17) is a rare subtype of type I autosomal dominant cerebellar ataxia (ADCA type I). It is characterized by a variable clinical picture which can include dementia, psychiatric disorders, parkinsonism, dystonia, chorea, spasticity, and epilepsy.	A rare subtype of type I autosomal dominant cerebellar ataxia (ADCA type I). It is characterized by a variable clinical picture which can include dementia, psychiatric disorders, parkinsonism, dystonia, chorea, spasticity, and epilepsy.
MONDO:0011875	definition	Any generalised epilepsy in which the cause of the disease is a mutation in the CLCN2 gene.	An inherited susceptibility or predisposition to developing epilepsy, idiopathic generalized, in which the cause of the disease is a mutation in the CLCN2 gene.
MONDO:0011997	definition	Hermansky-Pudlak syndrome type 2 (HPS-2) is a type of Hermansky-Pudlak syndrome (HPS), a multi-system disorder characterized by oculocutaneous albinism, bleeding diathesis and neutropenia.	A type of Hermansky-Pudlak syndrome (HPS), a multi-system disorder characterized by oculocutaneous albinism, bleeding diathesis and neutropenia.
MONDO:0012414	definition	Neuronal ceroid lipofuscinosis 10(CLN10-NCL) is arare condition that affects the nervous system. Signs and symptoms of the condition can develop any time from birth to adulthood and may include progressive dementia, seizures, lack of muscle coordination, and vision loss. CLN10-NCL is caused by changes (mutations) in the CTSD gene and is inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms.	A rare condition that affects the nervous system. Signs and symptoms of the condition can develop any time from birth to adulthood and may include progressive dementia, seizures, lack of muscle coordination, and vision loss. CLN10-NCL is caused by changes (mutations) in the CTSD gene and is inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms.
MONDO:0012627	definition	Any juvenile myoclonic epilepsy in which the cause of the disease is a mutation in the GABRA1 gene.	An inherited susceptibility or predisposition to developing juvenile myclonic epilepsy, idiopathic generalized epilepsy, or childhood absence epilepsy in which the cause of the disease is a mutation in the GABRA1 gene.
MONDO:0012763	definition	Any childhood absence epilepsy in which the cause of the disease is a mutation in the CACNA1H gene.	An inherited susceptibility or predisposition to developing child absence epilepsy or idiopathic generalized epilepsy, in which the cause of the disease is a mutation in the CACNA1H gene.
MONDO:0013103	definition	Any juvenile myoclonic epilepsy in which the cause of the disease is a mutation in the GABRD gene.	An inherited susceptibility or predisposition to developing epilepsy, idiopathic generalized, in which the cause of the disease is a mutation in the GABRD gene.
MONDO:0700075	definition	Any congenital muscular dystrophy in which the cause of the disease is a varation in the POMGNT2 gene.	Any congenital muscular dystrophy in which the cause of the disease is a variation in the POMGNT2 gene.
MONDO:0019609	definition	Zellweger syndrome (ZS) is the most severe variant seen in the peroxisome biogenesis disorders, Zellweger syndrome spectrum (PBD-ZSS), characterized by neuronal migration defects in the brain, dysmorphic craniofacial features, profound hypotonia, neonatal seizures, and liver dysfunction.	The most severe variant seen in the peroxisome biogenesis disorders that is characterized by neuronal migration defects in the brain, dysmorphic craniofacial features, profound hypotonia, neonatal seizures, and liver dysfunction.
MONDO:0700084	definition	Any myopathy in which the cause of the disease is a varation in the GMPPB gene.	Any myopathy in which the cause of the disease is a variation in the GMPPB gene.
MONDO:0014389	definition		A rare, genetic, glycogen storage disorder characterized by polyglucosan accumulation in various tissues, manifesting with progressive proximal muscle weakness in the lower limbs and rapidly progressive, usually dilated, cardiomyopathy. Hepatic involvement and growth retardation may be associated. Early-onset immunodeficiency and autoinflammation, presenting with recurrent bacterial infections, have also been reported.
MONDO:0015689	definition	Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement is a rare, malignant, neoplastic disease characterized by clonal proliferation of myeloid and/or lymphoid precursors harboring rearrangements in the PDGFRA gene, in the blood, bone marrow and often other tissues as well (spleen, lymph nodes, skin, etc.). It usually presents as chronic eosinophilic leukemia or, less commonly, as acute myeloid leukemia or T-lymphoblastic leukemia with eosinophilia. Patients usually present with eosinophilia, anemia, thrombocytopenia, neutrophilia, splenomegaly, lymphadenopathy, fever, sweating and/or weight loss. Tissue infiltration by eosinophils can manifest with skin rash, erythema, cough, neurological alterations, gastrointestinal symptoms or, rarely, endomyocardial fibrosis and restrictive cardiomyopathy.	A rare, malignant, neoplastic disease characterized by clonal proliferation of myeloid and/or lymphoid precursors harboring rearrangements in the PDGFRA gene, in the blood, bone marrow and often other tissues as well (spleen, lymph nodes, skin, etc.). It usually presents as chronic eosinophilic leukemia or, less commonly, as acute myeloid leukemia or T-lymphoblastic leukemia with eosinophilia. Patients usually present with eosinophilia, anemia, thrombocytopenia, neutrophilia, splenomegaly, lymphadenopathy, fever, sweating and/or weight loss. Tissue infiltration by eosinophils can manifest with skin rash, erythema, cough, neurological alterations, gastrointestinal symptoms or, rarely, endomyocardial fibrosis and restrictive cardiomyopathy.
MONDO:0015690	definition	Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement is a rare, malignant, neoplastic disease characterized by clonal proliferation of myeloid and/or lymphoid precursors harboring rearrangements in the PDGFRB gene, in the blood, bone marrow and often other tissues as well (spleen, lymph nodes, skin, etc.). It usually presents as chronic myelomonocytic leukemia with eosinophilia, chronic eosinophilic leukemia, atypical chronic myelogenous leukemia, juvenile myelomonocytic leukemia, myelodysplastic syndrome, acute myeloid leukemia or acute lymphoblastic leukemia. Patients usually present with anemia, leukocytosis, monocytosis, eosinophilia and/or splenomegaly, or systemic symptoms, such as fever, sweating and/or weight loss.	A rare, malignant, neoplastic disease characterized by clonal proliferation of myeloid and/or lymphoid precursors harboring rearrangements in the PDGFRB gene, in the blood, bone marrow and often other tissues as well (spleen, lymph nodes, skin, etc.). It usually presents as chronic myelomonocytic leukemia with eosinophilia, chronic eosinophilic leukemia, atypical chronic myelogenous leukemia, juvenile myelomonocytic leukemia, myelodysplastic syndrome, acute myeloid leukemia or acute lymphoblastic leukemia. Patients usually present with anemia, leukocytosis, monocytosis, eosinophilia and/or splenomegaly, or systemic symptoms, such as fever, sweating and/or weight loss.
MONDO:0016539	definition	Atypical hypotonia-cystinuria syndrome is a form of hypotonia-cystinuria type 1 syndrome characterized by mild to moderate intellectual disability in addition to classic hypotonia-cystinuria syndrome phenotype (cystinuria type 1, generalised hypotonia, poor feeding, growth retardation, and minor facial dysmorphism).	A form of hypotonia-cystinuria syndrome characterized by mild to moderate intellectual disability in addition to classic hypotonia-cystinuria syndrome phenotype (cystinuria type 1, generalised hypotonia, poor feeding, growth retardation, and minor facial dysmorphism).
MONDO:0016662	definition	Idiopathic recurrent pericarditis is a rare autoinflammatory syndrome defined as recurrence of pericardial inflammation of unknown origin following the first episode of acute pericarditis and a symptom-free interval of 4-6 weeks or longer. Recurrent attacks of chest pain may be the sole presentation or the chest pain may be accompanied by pericardial friction rub, electrocardiographic or echocardiographic changes, pericardial effusion and increased C-reactive protein. Cardiac tamponade is a rare, life-threatening complication.	A rare autoinflammatory syndrome defined as recurrence of pericardial inflammation of unknown origin following the first episode of acute pericarditis and a symptom-free interval of 4-6 weeks or longer. Recurrent attacks of chest pain may be the sole presentation or the chest pain may be accompanied by pericardial friction rub, electrocardiographic or echocardiographic changes, pericardial effusion and increased C-reactive protein. Cardiac tamponade is a rare, life-threatening complication.
MONDO:0017178	definition	Osteochondritis dissecans (OCD) is a rare bone disease characterized by an acquired idiopathic necrotic lesion of subchondral bone with the formation of a sequestrum, which may detach to form loose bodies in joints. OCD mainly affects the knee, ankle and elbow joints and can lead to pain, functional limitations and secondary osteoarthritis.	A rare genetic skeletal disorder characterized clinically by abnormal chondro-skeletal development, disproportionate short stature and skeletal deformation mainly affecting the knees, hips, ankles and elbows with onset generally in late childhood or adolescence.
MONDO:0017608	definition	Dystrophic epidermolysis bullosa (DEB) is a form of inherited epidermolysis bullosa (EB) characterized by cutaneous and mucosal fragility resulting in blisters and superficial ulcerations that develop below the lamina densa of the cutaneous basement membrane and that heal with significant scarring and milia formation. It comprises ten sub-types with the three most common being generalized dominant DEB (DDEB), severe generalized recessive DEB (RDEB- sev gen) and RDEB generalized-other.	
MONDO:0017681	definition	Erythrokeratoderma variabilis progressiva (EKVP) is a type of erythrokeratoderma characterized by the association of hyperkeratosis and erythema in persistent, although sometimes variable, circumscribed lesions. Progressive symmetric erythrokeratoderma (PSEK) and erythrokeratoderma variabilis (EKV) are probably no longer two distinctive diseases but rather the two clinical manifestations of a same disease, now known as EKVP.	A type of erythrokeratoderma characterized by the association of hyperkeratosis and erythema in persistent, although sometimes variable, circumscribed lesions. Progressive symmetric erythrokeratoderma (PSEK) and erythrokeratoderma variabilis (EKV) are probably no longer two distinctive diseases but rather the two clinical manifestations of a same disease, now known as EKVP.
MONDO:0018466	definition	A form of Parkinson disease (PD) characterized by an age of onset of more than 50 years, tremor at rest, gait complaints and falls, bradykinesia, rigidity and painful cramps. Patients usually present a low risk of developing non motor symptoms, dystonia, dyskinesia and levodopa-induced dyskinesia (LID).	
MONDO:0700069	definition	Any myopathy in which the cause of the disease is a varation in the POMGNT2 gene.	Any myopathy in which the cause of the disease is a variation in the POMGNT2 gene.
MONDO:0005503	obsoletion_candidate	True	
MONDO:0000881	obsoletion_candidate	True	
MONDO:0000882	obsoletion_candidate	True	
MONDO:0000883	obsoletion_candidate	True	
MONDO:0003127	obsoletion_candidate		True
MONDO:0006251	obsoletion_candidate		True
MONDO:0006475	obsoletion_candidate	True	
MONDO:0006728	obsoletion_candidate	True	
MONDO:0006785	obsoletion_candidate		True
MONDO:0009410	obsoletion_candidate		True
MONDO:0017957	obsoletion_candidate	True	
MONDO:0007600	obsoletion_candidate	True	
MONDO:0007684	obsoletion_candidate	True	
MONDO:0007815	obsoletion_candidate	True	
MONDO:0008091	obsoletion_candidate	True	
MONDO:0008122	obsoletion_candidate	True	
MONDO:0020244	obsoletion_candidate	True	
MONDO:0008956	obsoletion_candidate	True	
MONDO:0009004	obsoletion_candidate	True	
MONDO:0009494	obsoletion_candidate	True	
MONDO:0009535	obsoletion_candidate	True	
MONDO:0009654	obsoletion_candidate	True	
MONDO:0009799	obsoletion_candidate	True	
MONDO:0010302	obsoletion_candidate	True	
MONDO:0010527	obsoletion_candidate	True	
MONDO:0010674	obsoletion_candidate		True
MONDO:0011140	obsoletion_candidate		True
MONDO:0011329	obsoletion_candidate	True	
MONDO:0018162	obsoletion_candidate	True	
MONDO:0013617	obsoletion_candidate		True
MONDO:0019299	obsoletion_candidate	True	
MONDO:0015192	obsoletion_candidate	True	
MONDO:0016050	obsoletion_candidate		True
MONDO:0016538	obsoletion_candidate	True	
MONDO:0016665	obsoletion_candidate	True	
MONDO:0016754	obsoletion_candidate		True
MONDO:0016886	obsoletion_candidate	True	
MONDO:0016891	obsoletion_candidate	True	
MONDO:0016895	obsoletion_candidate	True	
MONDO:0016920	obsoletion_candidate	True	
MONDO:0017608	obsoletion_candidate	True	
MONDO:0018139	obsoletion_candidate	True	
MONDO:0018335	obsoletion_candidate		True
MONDO:0018348	obsoletion_candidate	True	
MONDO:0018466	obsoletion_candidate	True	
MONDO:0018750	obsoletion_candidate		True
MONDO:0019302	obsoletion_candidate	True	
MONDO:0020241	obsoletion_candidate	True	
MONDO:0020313	obsoletion_candidate	True	
MONDO:0020315	obsoletion_candidate	True	
MONDO:0021421	obsoletion_candidate		True
MONDO:0035398	obsoletion_candidate	True	
MONDO:0000881	obsolete		True
MONDO:0000882	obsolete		True
MONDO:0000883	obsolete		True
MONDO:0006475	obsolete		True
MONDO:0006728	obsolete		True
MONDO:0017957	obsolete		True
MONDO:0007684	obsolete		True
MONDO:0007815	obsolete		True
MONDO:0008091	obsolete		True
MONDO:0008122	obsolete		True
MONDO:0020244	obsolete		True
MONDO:0008956	obsolete		True
MONDO:0009004	obsolete		True
MONDO:0009494	obsolete		True
MONDO:0009535	obsolete		True
MONDO:0009654	obsolete		True
MONDO:0009799	obsolete		True
MONDO:0010527	obsolete		True
MONDO:0011329	obsolete		True
MONDO:0019299	obsolete		True
MONDO:0015192	obsolete		True
MONDO:0016538	obsolete		True
MONDO:0016665	obsolete		True
MONDO:0016886	obsolete		True
MONDO:0016891	obsolete		True
MONDO:0016895	obsolete		True
MONDO:0016920	obsolete		True
MONDO:0017608	obsolete		True
MONDO:0018139	obsolete		True
MONDO:0018348	obsolete		True
MONDO:0018466	obsolete		True
MONDO:0019302	obsolete		True
MONDO:0020241	obsolete		True
MONDO:0020313	obsolete		True
MONDO:0020315	obsolete		True
MONDO:0035398	obsolete		True
